Manufacturing Cell and Gene Therapy Products – The Revolution Is Here!

The Global Cell And Gene Therapy Market Is Estimated To Be Worth Between £9 to £14 Billion Per Year By 2025”

The race towards commercialisation of cell and gene products has already begun. Where technology innovations are pathing the way towards the development of these products, challenges surrounding scale up and closed system processing highlight areas that need our focus so that cell and gene therapy products can be produced on an industrial scale

The Cell and Gene Therapy Manufacturing Forum is the only conference that is 100% dedicated to focusing on development of manufacturing processes for these products. With presentations on improving cost efficiency, innovative strategies for commercialisation as well as closed system processing, optimised manufacturing scheduling and maintaining GMP compliance, this forum is one that is not to be missed!

Request Agenda

2017 Speakers Include:

View All Speakers

Attend This Forum To:


Determine what needs to be considered when moving from the research stage to commercial production, identifying the opportunities and challenges in ATMP


Look at the different challenges surrounding both open and closed system processing and identify the best approach to enhancing your system


Understand the best method for improving logistics and product stability at the final stages of the bio manufacturing process allowing you to start creating the optimal system


Study what the opportunities and barriers are when looking to scale up production allowing you to plan ahead for your manufacturing process


Scrutinise ways of improving manufacturing flexibility and cost efficiency in your manufacturing process and establish ways of moving towards a continuous bioprocess

What did previous attendees have to say?

Sneak Peak At Our Other Manufacturing Conferences

Sponsors & Exhibitors
Media Partners